Latest breakthroughs in cancer research, treatment, and prevention
311 articles
Revolutionary liquid biopsy technology uses nanoparticles to detect cancer biomarkers in blood with exceptional precision.
Researchers discover why combining chemotherapy with immunotherapy works better and identify a key resistance mechanism.
Dr. Kerry Courneya reveals how structured exercise becomes therapeutic intervention that enhances treatment tolerance and survival.
Researchers discovered how to restore tumor-killing power in worn-out immune cells by switching off just two genes.
New AI tool automatically identifies cells with chromosomal defects that may lead to cancer, helping scientists study how cancer begins.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Phase II trial tests checkpoint inhibitors given before surgery to shrink tumors and improve outcomes in stage III-IV melanoma patients.
New viral therapy ASP9801 targets solid tumors directly, potentially offering hope for patients with advanced metastatic cancer.
First study tests whether supervised exercise training is safe and beneficial for bladder cancer patients during treatment.
